Clinical Application of Liquid Biopsy in Targeted Therapy of Metastatic Colorectal Cancer
Background. Colorectal cancers (CRC) shed DNA into blood circulation. There is growing evidence that the analysis of circulating tumor DNA can be effectively used for monitoring of disease, to track tumor heterogeneity and to evaluate response to treatment. Case Presentation. Here, we describe two c...
Main Authors: | Jörg Trojan, Susanne Klein-Scory, Christine Koch, Wolff Schmiegel, Alexander Baraniskin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/6139634 |
Similar Items
-
Significance of Liquid Biopsy for Monitoring and Therapy Decision of Colorectal Cancer
by: Susanne Klein-Scory, et al.
Published: (2018-04-01) -
Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
by: Susanne Klein-Scory, et al.
Published: (2020-07-01) -
Clinical Perspectives on Liquid Biopsy in Metastatic Colorectal Cancer
by: Wei Gao, et al.
Published: (2021-01-01) -
Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL
by: Alexander Baraniskin, et al.
Published: (2021-05-01) -
Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.
by: Jun-Kyu Kang, et al.
Published: (2020-01-01)